Dariusz Ladon

Adelaide, SA, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort.

Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort.

Journal: Blood cancer journal

Published: December 27, 2024

Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutations.

Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutations.

Journal: Blood advances

Published: November 04, 2024

Myeloid neoplasms arising after methotrexate therapy for autoimmune rheumatological diseases do not exhibit poor-risk molecular features.

Myeloid neoplasms arising after methotrexate therapy for autoimmune rheumatological diseases do not exhibit poor-risk molecular features.

Journal: Blood cancer journal

Published: May 09, 2024

Unraveling facets of MECOM-associated syndrome: somatic genetic rescue, clonal hematopoiesis, and phenotype expansion.

Unraveling facets of MECOM-associated syndrome: somatic genetic rescue, clonal hematopoiesis, and phenotype expansion.

Journal: Blood advances

Published: December 04, 2023

TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms.

TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms.

Journal: Blood cancer journal

Published: January 19, 2023

TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype.

TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype.

Journal: Blood

Published: September 06, 2022

A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program.

A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program.

Journal: Nature communications

Published: November 19, 2020

Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich Syndrome.

Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich Syndrome.

Journal: Nature communications

Published: September 26, 2019

DNA methylation-based profiling for paediatric CNS tumour diagnosis and treatment: a population-based study.

DNA methylation-based profiling for paediatric CNS tumour diagnosis and treatment: a population-based study.

Journal: The Lancet. Child & adolescent health

Published: August 07, 2019

Long Terminal Repeat CRISPR-CAR-Coupled "Universal" T Cells Mediate Potent Anti-leukemic Effects.

Long Terminal Repeat CRISPR-CAR-Coupled "Universal" T Cells Mediate Potent Anti-leukemic Effects.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: November 10, 2017

Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders.

Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders.

Journal: Haematologica

Published: February 29, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026